AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The primary objective is to determine if AMG 853 is effective compared with placebo as
measured by change in Asthma Control Questionnaire (ACQ) composite symptoms scores from
baseline to week 12.